What is Xarelto?
Xarelto, a blood thinner manufactured to reduce the risk of blood clots by Bayer and marketed by Johnson & Johnson, is currently involved in a multidistrict litigation (MDL) to centralize lawsuits claiming that Xarelto did not properly warn of uncontrolled bleeding side effects and the lack of a reversal agent (antidote).
The U.S. Food and Drug Administration (FDA) maintains a database of “adverse event reports” to monitor injuries reported while using a specific drug or medical device. Quarterwatch, a publication issued by the Institute of Safe Medication Practices (ISMP), noted that there were 680 adverse event reports associated with Xarelto in 2013—more than similar blood thinner Pradaxa, whose manufacturer Boehringer Ingelheim settled lawsuits for $650 million in May 2014.
There is currently no full recall of Xarelto, though plaintiffs filing lawsuits have urged for a recall until a reversal agent can be developed to reverse the potentially serious uncontrolled bleeding side effects of Xarelto.
Johnson & Johnson did issue a recall of a 13,500 bottles of Xarelto due to contamination from a plant in Puerto Rico (Fierce Pharma Manufacturing), but a complete recall pulling Xarelto off the market has not been issued.
Xarelto Side Effects
Briefly, the types of uncontrolled bleeding related to Xarelto include, but may not be limited to:
- rectal bleeding,
- intestinal or abdominal bleeds,
- hemorrhaging, and/or
- bleeding in the brain.
Have You Experienced Bleeding Side Effects from Xarelto Use?
Patients who have experienced uncontrolled bleeding or other similar side effects from using Xarelto may wish to speak to a lawyer to find out if they are eligible to file a lawsuit. For more information about whether you may have a case, contact the attorneys at Hissey Kientz, LLP by calling toll-free at 1-866-275-4454 or by filling out the contact form on this page.